Oncocidin A1: A novel tubulin-binding drug with antitumor activity against human breast and ovarian carcinoma xenografts in nude mice

Biochemical Pharmacology

Volumn 56, Issue 5, 1998, Pages 623-633

  Chen, Xiaoying ^a   Pine, Polly ^a   Knapp, A Merrill ^a   Tusé, Daniel ^b   Laderoute, Keith R ^a  

^a SRI INTERNATIONAL   (United States)

^b Biosource Technologies Inc   (United States)

Author keywords

Colchicine; Combretastatin; Mitotic arrest; Spindle assembly; Thyroid hormone; Tubulin

Indexed keywords

3,5 DIIODO 4 (4' METHOXYPHENOXY)BENZOIC ACID METHYL ESTER; ANTINEOPLASTIC AGENT; NEW DRUG; THYROID HORMONE DERIVATIVE; TUBULIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CARCINOMA; CANCER GRAFT; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; MICROTUBULE ASSEMBLY; MONKEY; NONHUMAN; NUDE MOUSE; OVARY CARCINOMA; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ANIMALS; ANTINEOPLASTIC AGENTS; BIOLOGICAL AVAILABILITY; BREAST NEOPLASMS; CELL DIVISION; FEMALE; HUMANS; IODOBENZOATES; METAPHASE; MICE; MICE, NUDE; MITOSIS; NEOPLASM TRANSPLANTATION; OVARIAN NEOPLASMS; PHENYL ETHERS; PROTEIN BINDING; TRANSPLANTATION, HETEROLOGOUS; TUBULIN;

EID: 0032169560     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(98)00210-X     Document Type: Article

References (33)

1. Borrows E.T., Clayton J.C., Hems B.A. The synthesis of thyroxine and related substances. Part I. The preparation of tyrosine and some of its derivatives, and a new route to thyroxine. J Chem Soc. 1949;S185-S190.
2. 135I uptake by the rat thyroid. Endocrinology. 64:1959;123-125.
3. Stasilli N.R., Kroc R.L., Meltzer R.I. Antigoitrogenic and calorigenic activities of thyroxine analogues in rats. Endocrinology. 64:1959;62-82.
4. Kun E., Mendeleyev J., Bauer P.I., Kirsten E., Zhen J., Young L.T., Vidair C.A., Pine P. Induction of tumor apoptosis by methyl-3,5-diiodo-4-(4′-methoxyphenoxy)benzoate (DIME). Int J Oncol (Suppl). 9:1996;829.
5. Darzynkiewicz Z., Li X., Gong J. Assays of cell viability Discrimination of cells dying by apoptosis . Methods Cell Biol. 41:1994;15-38.
6. Hyman A., Kellogg D., Sawin K., Wordeman L., Mitchison T.J. Preparation and properties of modified tubulins. Methods Enzymol. 196:1990;478-485.
7. Belmont L., Mitchison T.J. Identification of a protein that interacts with tubulin dimers and increases the catastrophe rate of microtubules. Cell. 84:1996;623-631.
8. Woods J.A., Hadfield J.A., Pettit G.R., Fox B.W., McGown A.T. The interaction with tubulin of a series of stilbenes based on combretastatin A-4. Br J Cancer. 71:1995;705-711.
9. Smith C.D., Zhang X. Mechanism of action of cryptophycin. J Biol Chem. 271:1996;6192-6198.
10. Hamel E., Lin C.M. Interaction of a new antimitotic agent, NSC-181928, with purified tubulin. Biochem Biophys Res Commun. 104:1982;929-936.
11. McGown A.T., Fox B.W. Structural and biochemical comparison of the antimitotic agents colchicine, combretastatin A4 and amphethinile. Anticancer Drug Des. 3:1989;249-254.
12. Wu X., Bishopric N.H., Discher D.J., Murphy B.J., Webster K.A. Physical and functional sensitivity of zinc finger transcription factors to redox change. Mol Cell Biol. 16:1996;1035-1046.
13. Wylie A.H. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature. 284:1980;555-556.
14. Wheater P.R., Burkitt H.G., Daniels V.G. Functional Histology. 1979;Churchill Livingstone, London.
15. Wilson L., Jordan M.A. Pharmacological probes of microtubule function. Hyams J.S., Lloyd C.W. Microtubules. 1994;59-83 Wiley-Liss, New York.
16. Elledge S.J. Cell cycle checkpoints Preventing an identity crisis . Science. 274:1996;1664-1672.
17. Burns R.G., Surridge C.D. Tubulin Conservation and structure . Hyams J.S., Lloyd C.W. Microtubules. 1994;3-31 Wiley-Liss, New York.
18. Mitchison T., Kirschner M. Dynamic instability of microtubule growth. Nature. 312:1984;237-242.
19. Hamel E. Antimitotic natural products and their interactions with tubulin. Med Res Rev. 16:1996;207-231.
20. Bai R., Cichacz Z.A., Herald C.L., Pettit G.R., Hamel E. Spongistatin 1, a highly cytotoxic, sponge-derived, marine natural product that inhibits mitosis, microtubule assembly, and the binding of vinblastine to tubulin. Mol Pharmacol. 44:1993;757-766.
21. Wilson L., Jordan M.A. Microtubule dynamics Taking aim at a moving target . Chem Biol. 2:1995;569-573.
22. Graupner G., Wills K.N., Tzukerman M., Zhang X.K., Pfahl M. Dual regulatory role for thyroid-hormone receptors allows control of retinoic-acid receptor activity. Nature. 340:1989;653-656.
23. Rowinsky E.K., Donehower R.C. The clinical pharmacology and use of antimicrotubule agents in cancer chemotherapeutics. Pharmacol Ther. 52:1991;35-84.
24. Rowinsky E.K., Donehower R.C. Paclitaxel (taxol). N Engl J Med. 332:1995;1004-1014.
25. Sontag E., Nunbhakdi-Craig V., Bloom G.S., Mumby M.C. A novel pool of protein phosphatase 2A is associated with microtubules and is regulated during the cell cycle. J Cell Biol. 128:1995;1131-1144.
26. Merrick S.E., Demoise D.C., Lee V.M. Site-specific dephosphorylation of tau protein at Ser202/Thr205 in response to microtubule depolymerization in cultured human neurons involves protein phosphatase 2A. J Biol Chem. 271:1996;5589-5594.
27. Camerman N., Camerman A. Triiodothyronine The 3′-iodine is proximal to the α-ring in crystal structure conformation . Science. 175:1972;764-766.
28. Jorgensen E.C. Structure-activity relationships of thyroxine analogs. Pharmacol Ther. 2:1976;661-682.
29. Hastie S.B. Interactions of colchicine with tubulin. Pharmacol Ther. 51:1991;377-401.
30. Wagner R.L., Apriletti J.W., West B.L., Ramalingam V., Baxter J.D., Fletterick R.L. A structural role for hormone in the thyroid hormone receptor. Nature. 378:1995;690-697.
31. D'Amato R.J., Lin C.M., Flynn E., Folkman J., Hamel E. 2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site. Proc Natl Acad Sci USA. 91:1994;3964-3968.
32. Klauber N., Parangi S., Flynn E., Hamel E., D'Amato R.J. Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol. Cancer Res. 57:1997;81-86.
33. Dark G.G., Hill S.A., Prise V.E., Tozer G.M., Pettit G.R., Chaplin D. Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature. Cancer Res. 57:1997;1829-1834.